Why the study?
What is the clinical profile and prognostic impact of atrial fibrillation in patients with hypertrophic cardiomyopathy?
What is the clinical profile and prognostic impact of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Atrial fibrillation in hypertrophic cardiomyopathy does not significantly increase disease-related mortality or sudden death when treated, though it carries a risk of embolic stroke supporting early anticoagulation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rowin et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: